| Description | Priliximab (CEN 000029), an anti-CD4 humanized monoclonal antibody, binds to CD4 receptors on T cells, leading to a significant and sustained decrease in circulating CD4+ T cells. This property renders it useful in the study of rheumatoid arthritis (RA) [1]. |
| Synonyms | cM-T412, CEN 000029 |
| molecular weight | N/A |
| CAS | 147191-91-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |